Optimized glycemic control of type 2 diabetes with reinforcement learning: a proof-of-concept trial

[1]  M. H. Jensen,et al.  Time for Using Machine Learning for Dose Guidance in Titration of People With Type 2 Diabetes? A Systematic Review of Basal Insulin Dose Guidance. , 2022, Journal of diabetes science and technology.

[2]  Eric L. Johnson,et al.  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. , 2022, Diabetes care.

[3]  R. Vatankhah,et al.  Subcutaneous insulin administration by deep reinforcement learning for blood glucose level control of type-2 diabetic patients , 2022, Comput. Biol. Medicine.

[4]  SeungYeon Kang,et al.  Reinforcement learning-based expanded personalized diabetes treatment recommendation using South Korean electronic health records , 2022, Expert Syst. Appl..

[5]  B. Luo,et al.  Beyond Greedy Search: Tracking by Multi-Agent Reinforcement Learning-Based Beam Search , 2022, IEEE Transactions on Image Processing.

[6]  Spiros C. Denaxas,et al.  Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI , 2022, Nature Medicine.

[7]  Hongyan Liu,et al.  Learning dynamic treatment strategies for coronary heart diseases by artificial intelligence: real-world data-driven study , 2022, BMC Medical Informatics and Decision Making.

[8]  Haonan Yu,et al.  Generative Planning for Temporally Coordinated Exploration in Reinforcement Learning , 2022, ICLR.

[9]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[10]  Shenda Hong,et al.  Personalized vital signs control based on continuous action-space reinforcement learning with supervised experience , 2021, Biomed. Signal Process. Control..

[11]  Daniel S. Kermany,et al.  Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images , 2021, Nature Biomedical Engineering.

[12]  C. Catton,et al.  Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer , 2021, Nature Medicine.

[13]  Tao Yu,et al.  A deep-learning pipeline for the diagnosis and discrimination of viral, non-viral and COVID-19 pneumonia from chest X-ray images , 2021, Nature Biomedical Engineering.

[14]  G. Umpierrez,et al.  Glycemic variability and cardiovascular disease in patients with type 2 diabetes , 2021, BMJ Open Diabetes Research & Care.

[15]  J. Hugo,et al.  Designing an integrated, nurse-driven and home-based digital intervention to improve insulin management in under-resourced settings , 2021, Therapeutic advances in endocrinology and metabolism.

[16]  6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. , 2021, Diabetes care.

[17]  Mengling Feng,et al.  A Deep Reinforcement Learning Approach for Type 2 Diabetes Mellitus Treatment , 2020, 2020 IEEE International Conference on Healthcare Informatics (ICHI).

[18]  Giuseppe De Pietro,et al.  Reinforcement learning for intelligent healthcare applications: A survey , 2020, Artif. Intell. Medicine.

[19]  Qingyan Huang,et al.  Model-Based or Model-Free, a Review of Approaches in Reinforcement Learning , 2020, 2020 International Conference on Computing and Data Science (CDS).

[20]  Demis Hassabis,et al.  Mastering Atari, Go, chess and shogi by planning with a learned model , 2019, Nature.

[21]  J. Wiens,et al.  Reinforcement Learning for Blood Glucose Control: Challenges and Opportunities , 2019 .

[22]  Raymond Y Huang,et al.  Artificial intelligence in cancer imaging: Clinical challenges and applications , 2019, CA: a cancer journal for clinicians.

[23]  Fredrik D. Johansson,et al.  Guidelines for reinforcement learning in healthcare , 2019, Nature Medicine.

[24]  Aldo A. Faisal,et al.  The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care , 2018, Nature Medicine.

[25]  Lu Wang,et al.  Supervised Reinforcement Learning with Recurrent Neural Network for Dynamic Treatment Recommendation , 2018, KDD.

[26]  Daniel S. Kermany,et al.  Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning , 2018, Cell.

[27]  Mehrdad Farajtabar,et al.  More Robust Doubly Robust Off-policy Evaluation , 2018, ICML.

[28]  Andreas Spanias,et al.  Attend and Diagnose: Clinical Time Series Analysis using Attention Models , 2017, AAAI.

[29]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[30]  Shamim Nemati,et al.  Optimal medication dosing from suboptimal clinical examples: A deep reinforcement learning approach , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[31]  Luca Martino,et al.  Effective sample size for importance sampling based on discrepancy measures , 2016, Signal Process..

[32]  A. Aldo Faisal,et al.  The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas , 2013, Expert review of medical devices.

[33]  Limin Peng,et al.  Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes , 2013, Diabetes Care.

[34]  David Rodbard,et al.  Glycemic variability: measurement and utility in clinical medicine and research--one viewpoint. , 2011, Diabetes technology & therapeutics.

[35]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[36]  Limin Peng,et al.  Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[37]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[38]  S. Garg,et al.  Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. , 2008, Diabetes technology & therapeutics.

[39]  I. Hirsch,et al.  A Real-World Approach to Insulin Therapy in Primary Care Practice , 2005 .

[40]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[41]  Andrew W. Moore,et al.  Reinforcement Learning: A Survey , 1996, J. Artif. Intell. Res..

[42]  Jun S. Liu,et al.  Sequential Imputations and Bayesian Missing Data Problems , 1994 .

[43]  Wenlong Fu,et al.  Model-based reinforcement learning: A survey , 2018 .

[44]  L. Kennedy,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .

[45]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..